You are here

  • Home
  • Archive
  • Volume 22, Issue 2
  • Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes

Article metrics

Article menu

Download PDFPDF

Perspective
Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes
Free

 

Online download statistics by month:

Online download statistics by month: March 2017 to March 2024

AbstractFullPdf
Mar 2017042683
Apr 2017032071
May 2017031546
Jun 2017017634
Jul 20170112
Aug 20170456
Sep 20170598
Oct 20170379
Nov 20170297
Dec 20170217
Jan 20180254
Feb 20180246
Mar 201803413
Apr 20180165
May 20180258
Jun 20180265
Jul 20180173
Aug 201802213
Sep 20180169
Oct 201803323
Nov 201802015
Dec 20180199
Jan 201903120
Feb 201902830
Mar 201901522
Apr 201901713
May 201902811
Jun 201901810
Jul 201901617
Aug 201902516
Sep 201902912
Oct 201901713
Nov 201901810
Dec 20190148
Jan 20200237
Feb 20200195
Mar 20200144
Apr 20200287
May 20200143
Jun 20200179
Jul 20200195
Aug 202001210
Sep 20200184
Oct 20200126
Nov 20200135
Dec 2020095
Jan 20210187
Feb 2021058
Mar 202103919
Apr 20210157
May 2021093
Jun 20210134
Jul 2021086
Aug 2021077
Sep 2021077
Oct 202101228
Nov 20210916
Dec 202102711
Jan 20220159
Feb 20220175
Mar 20220196
Apr 20220164
May 202202513
Jun 20220235
Jul 20220133
Aug 20220265
Sep 202202413
Oct 20220236
Nov 20220134
Dec 2022097
Jan 20230103
Feb 20230234
Mar 2023053
Apr 20230297
May 2023024
Jun 20230103
Jul 2023065
Aug 2023038
Sep 202301012
Oct 20230111
Nov 2023052
Dec 20230134
Jan 20240177
Feb 2024078
Mar 202401147
Total02714969